Sacituzumab govitecan come seconda linea nell’algoritmo terapeutico delle pazienti ricadute precocemente dal termine della terapia neoadiuvante

MeSH terms

• Algorithms*
• Antibodies, Monoclonal, Humanized* / administration & dosage
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Antineoplastic Agents, Immunological / administration & dosage
• Antineoplastic Agents, Immunological / therapeutic use
• Breast Neoplasms / drug therapy
• Breast Neoplasms / pathology
• Camptothecin / administration & dosage
• Camptothecin / analogs & derivatives
• Camptothecin / therapeutic use
• Female
• Humans
• Immunoconjugates
• Middle Aged
• Neoadjuvant Therapy* / methods
• Neoplasm Recurrence, Local